Lidamidine

DB21098ExperimentalSmall molecule

Lidamidine is a small molecule drug. Lidamidine has a monoisotopic molecular weight of 220.13 Da.

Mechanism: Pharmacologically active on Alpha-2 adrenergic receptors
Curator reviewed
Formula / weight: C₁₁H₁₆N₄O · 220.276 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyRRHJHSBDJDZUGL-UHFFFAOYSA-NSMILESCNC(=N)NC(=O)NC1=C(C)C=CC=C1C

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Lidamidine, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.